266 related articles for article (PubMed ID: 20197468)
1. Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma.
Becher OJ; Hambardzumyan D; Walker TR; Helmy K; Nazarian J; Albrecht S; Hiner RL; Gall S; Huse JT; Jabado N; MacDonald TJ; Holland EC
Cancer Res; 2010 Mar; 70(6):2548-57. PubMed ID: 20197468
[TBL] [Abstract][Full Text] [Related]
2. PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma.
Barton KL; Misuraca K; Cordero F; Dobrikova E; Min HD; Gromeier M; Kirsch DG; Becher OJ
PLoS One; 2013; 8(10):e77639. PubMed ID: 24098593
[TBL] [Abstract][Full Text] [Related]
3. A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.
Misuraca KL; Hu G; Barton KL; Chung A; Becher OJ
Neoplasia; 2016 Jan; 18(1):60-70. PubMed ID: 26806352
[TBL] [Abstract][Full Text] [Related]
4. Pax3 expression enhances PDGF-B-induced brainstem gliomagenesis and characterizes a subset of brainstem glioma.
Misuraca KL; Barton KL; Chung A; Diaz AK; Conway SJ; Corcoran DL; Baker SJ; Becher OJ
Acta Neuropathol Commun; 2014 Oct; 2():134. PubMed ID: 25330836
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells.
de la Peña L; Burgan WE; Carter DJ; Hollingshead MG; Satyamitra M; Camphausen K; Tofilon PJ
Mol Cancer Ther; 2006 Jun; 5(6):1504-10. PubMed ID: 16818509
[TBL] [Abstract][Full Text] [Related]
6. Perifosine inhibits multiple signaling pathways in glial progenitors and cooperates with temozolomide to arrest cell proliferation in gliomas in vivo.
Momota H; Nerio E; Holland EC
Cancer Res; 2005 Aug; 65(16):7429-35. PubMed ID: 16103096
[TBL] [Abstract][Full Text] [Related]
7. Pre-Clinical Study of Panobinostat in Xenograft and Genetically Engineered Murine Diffuse Intrinsic Pontine Glioma Models.
Hennika T; Hu G; Olaciregui NG; Barton KL; Ehteda A; Chitranjan A; Chang C; Gifford AJ; Tsoli M; Ziegler DS; Carcaboso AM; Becher OJ
PLoS One; 2017; 12(1):e0169485. PubMed ID: 28052119
[TBL] [Abstract][Full Text] [Related]
8. Pre-irradiation intensive induction and marrow-ablative consolidation chemotherapy in young children with newly diagnosed high-grade brainstem gliomas: report of the "head-start" I and II clinical trials.
Osorio DS; Patel N; Ji L; Sposto R; Stanek J; Gardner SL; Allen JC; Cornelius A; McCowage GB; Termuhlen A; Dunkel IJ; Comito M; Garvin J; Finlay JL
J Neurooncol; 2018 Dec; 140(3):717-725. PubMed ID: 30392092
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of convection-enhanced delivery of liposomal doxorubicin to treat pediatric diffuse intrinsic pontine glioma and thalamic high-grade glioma.
Sewing ACP; Lagerweij T; van Vuurden DG; Meel MH; Veringa SJE; Carcaboso AM; Gaillard PJ; Peter Vandertop W; Wesseling P; Noske D; Kaspers GJL; Hulleman E
J Neurosurg Pediatr; 2017 May; 19(5):518-530. PubMed ID: 28291423
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy for brainstem gliomas in children and adults: A single-institution experience and literature review.
Yoshida K; Sulaiman NS; Miyawaki D; Ejima Y; Nishimura H; Ishihara T; Matsuo Y; Nishikawa R; Sasayama T; Hayakawa A; Kohmura E; Sasaki R
Asia Pac J Clin Oncol; 2017 Apr; 13(2):e153-e160. PubMed ID: 26935004
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput in vitro drug screen in a genetically engineered mouse model of diffuse intrinsic pontine glioma identifies BMS-754807 as a promising therapeutic agent.
Halvorson KG; Barton KL; Schroeder K; Misuraca KL; Hoeman C; Chung A; Crabtree DM; Cordero FJ; Singh R; Spasojevic I; Berlow N; Pal R; Becher OJ
PLoS One; 2015; 10(3):e0118926. PubMed ID: 25748921
[TBL] [Abstract][Full Text] [Related]
12. ABCG2 and ABCB1 Limit the Efficacy of Dasatinib in a PDGF-B-Driven Brainstem Glioma Model.
Mittapalli RK; Chung AH; Parrish KE; Crabtree D; Halvorson KG; Hu G; Elmquist WF; Becher OJ
Mol Cancer Ther; 2016 May; 15(5):819-29. PubMed ID: 26883271
[TBL] [Abstract][Full Text] [Related]
13. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
Marcus KJ; Dutton SC; Barnes P; Coleman CN; Pomeroy SL; Goumnerova L; Billett AL; Kieran M; Tarbell NJ
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1182-5. PubMed ID: 12654425
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma.
McConville P; Hambardzumyan D; Moody JB; Leopold WR; Kreger AR; Woolliscroft MJ; Rehemtulla A; Ross BD; Holland EC
Clin Cancer Res; 2007 May; 13(10):2897-904. PubMed ID: 17504989
[TBL] [Abstract][Full Text] [Related]
15. Genetically engineered rat gliomas: PDGF-driven tumor initiation and progression in tv-a transgenic rats recreate key features of human brain cancer.
Connolly NP; Stokum JA; Schneider CS; Ozawa T; Xu S; Galisteo R; Castellani RJ; Kim AJ; Simard JM; Winkles JA; Holland EC; Woodworth GF
PLoS One; 2017; 12(3):e0174557. PubMed ID: 28358926
[TBL] [Abstract][Full Text] [Related]
16. Brainstem glioma: Prediction of histopathologic grade based on conventional MR imaging.
Moharamzad Y; Sanei Taheri M; Niaghi F; Shobeiri E
Neuroradiol J; 2018 Feb; 31(1):10-17. PubMed ID: 29148317
[TBL] [Abstract][Full Text] [Related]
17. Concurrent carbogen and radiation therapy in children with high-risk brainstem gliomas.
Aquino-Parsons C; Hukin J; Green A
Pediatr Blood Cancer; 2008 Feb; 50(2):397-9. PubMed ID: 17009221
[TBL] [Abstract][Full Text] [Related]
18. Poly-ADP-Ribose Polymerase as a Therapeutic Target in Pediatric Diffuse Intrinsic Pontine Glioma and Pediatric High-Grade Astrocytoma.
Chornenkyy Y; Agnihotri S; Yu M; Buczkowicz P; Rakopoulos P; Golbourn B; Garzia L; Siddaway R; Leung S; Rutka JT; Taylor MD; Dirks PB; Hawkins C
Mol Cancer Ther; 2015 Nov; 14(11):2560-8. PubMed ID: 26351319
[TBL] [Abstract][Full Text] [Related]
19. Pre-radiation chemotherapy improves survival in pediatric diffuse intrinsic pontine gliomas.
Gokce-Samar Z; Beuriat PA; Faure-Conter C; Carrie C; Chabaud S; Claude L; Di Rocco F; Mottolese C; Szathmari A; Chabert C; Frappaz D
Childs Nerv Syst; 2016 Aug; 32(8):1415-23. PubMed ID: 27379495
[TBL] [Abstract][Full Text] [Related]
20. Bevacizumab and irinotecan treatment for progressive diffuse brainstem glioma: case report.
Torcuator R; Zuniga R; Loutfi R; Mikkelsen T
J Neurooncol; 2009 Jul; 93(3):409-12. PubMed ID: 19139822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
